{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T16:40:14Z","timestamp":1685983214498},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10067-011-1704-7","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T01:48:49Z","timestamp":1299462529000},"page":"1095-1098","source":"Crossref","is-referenced-by-count":8,"title":["Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?"],"prefix":"10.1007","volume":"30","author":[{"given":"Muhammad","family":"Haroon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead","family":"Harney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"issue":"12","key":"1704_CR1","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.4049\/jimmunol.152.12.5883","volume":"152","author":"NW Lukacs","year":"1994","unstructured":"Lukacs NW, Chensue SW, Strieter RM, Warmington K, Kunkel SL (1994) Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1. J Immunol 152(12):5883\u20135889","journal-title":"J Immunol"},{"issue":"7","key":"1704_CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Drent M, Kavuru M et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174(7):795\u2013802","journal-title":"Am J Respir Crit Care Med"},{"key":"1704_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","volume":"53","author":"K Phillips","year":"2005","unstructured":"Phillips K, Weinblatt M (2005) Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 53:618\u2013620","journal-title":"Arthritis Rheum"},{"key":"1704_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/thorax.58.3.278","volume":"58","author":"SR Vavricka","year":"2003","unstructured":"Vavricka SR, Wettstein T, Speich R, Gaspert A, Bachli EB (2003) Pulmonary granulomas after tumour necrosis factor. Thorax 58:278\u2013279","journal-title":"Thorax"},{"key":"1704_CR5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","volume":"122","author":"L Peno-Green","year":"2002","unstructured":"Peno-Green L, Lluberas G, Kingsley T, Brantley S (2002) Lung injury linked to etanercept therapy. Chest 122:1858\u20131860","journal-title":"Chest"},{"key":"1704_CR6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10535","volume":"47","author":"G Cunnane","year":"2005","unstructured":"Cunnane G, Warnock M, Fye KH, Daikh DI (2005) Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 47:445\u2013449","journal-title":"Arthritis Rheum"},{"key":"1704_CR7","first-page":"752","volume":"32","author":"J Oh","year":"2005","unstructured":"Oh J, Arkfeld DG, Horwitz DA (2005) Development of Crohn\u2019s disease in a patient taking etanercept. J Rheumatol 32:752\u2013753","journal-title":"J Rheumatol"},{"issue":"4","key":"1704_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00296-008-0691-8","volume":"29","author":"SK Metyas","year":"2009","unstructured":"Metyas SK, Tadros RM, Arkfeld DG (2009) Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Rheumatol Int 29(4):437\u2013439","journal-title":"Rheumatol Int"},{"issue":"8","key":"1704_CR9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","volume":"48","author":"CI Da\u00efen","year":"2009","unstructured":"Da\u00efen CI, Monnier A, Claudepierre P et al (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 48(8):883\u2013886","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1704_CR10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2007.078840","volume":"67","author":"GH Louie","year":"2008","unstructured":"Louie GH, Chitkara P, Ward MM (2008) Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis 67(6):896\u2013898","journal-title":"Ann Rheum Dis"},{"key":"1704_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","volume":"124","author":"JP Utz","year":"2003","unstructured":"Utz JP, Limper AH, Kalra S et al (2003) Etanercept for the treatment of stage II and III. Progressive pulmonary sarcoidosis. Chest 124:177\u2013185","journal-title":"Chest"},{"key":"1704_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","unstructured":"Wegener\u2019s Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 352:351\u2013361","journal-title":"N Engl J Med"},{"key":"1704_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","volume":"121","author":"WJ Sandborn","year":"2001","unstructured":"Sandborn WJ, Hanauer SB, Katz S et al (2001) Etanercept for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121:1088\u20131094","journal-title":"Gastroenterology"},{"key":"1704_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","volume":"36","author":"DE Furst","year":"2006","unstructured":"Furst DE, Wallis R, Broder M, Beenhouwer DO (2006) Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 36:159\u2013167","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1704_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0973-3698(10)60006-4","volume":"1","author":"VR Tandon","year":"2006","unstructured":"Tandon VR, Mahajan A, Khajuria V (2006) TNF inhibitors and tuberculosis: an Indian concern. J Ind Rheumatol Assoc 1(2):66\u201371","journal-title":"J Ind Rheumatol Assoc"},{"issue":"2","key":"1704_CR16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","volume":"301","author":"B Scallon","year":"2002","unstructured":"Scallon B, Cai A, Solowski N et al (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301(2):418\u2013426","journal-title":"J Pharmacol Exp Ther"},{"key":"1704_CR17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.166.1.642","volume":"166","author":"K Shigehara","year":"2001","unstructured":"Shigehara K, Shijubo N, Ohmichi M et al (2001) IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166:642","journal-title":"J Immunol"},{"issue":"4","key":"1704_CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0009-9236(02)17635-1","volume":"73","author":"H Lee","year":"2003","unstructured":"Lee H, Kimko HC, Rogge M, Wang D, Nestorov I, Peck CC (2003) Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clin Pharmacol Ther 73(4):348\u2013365","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1704-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1704-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T16:08:45Z","timestamp":1685981325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1704-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1704"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1704-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}